GUSTO Trial
(Last Updated - 11/18/2006)
-study showed increased survival w/ t-PA & unfractionated Heparin (UFH) vs. other fibrinolytic options
-t-PA & UFH:
-6.3% mortality
-t-PA & Streptokinase & UFH:
-7.0% mortality
-Streptokinase & sub-Q Heparin (SQ Hep):
-7.2% mortality
-Streptokinase & UFH:
-7.4% mortality
==============================================
References:
NEJM: 9/2/1993: 329(10): p. 673-682